Get the Stockscreener App
32.28
3.18%
-1.06
After Hours:
32.28
Omnicell Inc stock is traded at $32.28, with a volume of 742.50K.
It is down -3.18% in the last 24 hours and down -19.75% over the past month.
Omnicell Inc provides automation and business analytics software for healthcare providers. It helps its customers to define and deliver cost-effective medication management that is designed to equip and empower pharmacists and nurses to focus on patient care rather than administrative tasks, and to drive improved clinical, operational, and financial outcomes across all care settings. Omnicell generates the vast majority of its revenue in the United States.
See More
Previous Close:
$33.34
Open:
$33.47
24h Volume:
742.50K
Relative Volume:
1.69
Market Cap:
$1.48B
Revenue:
$1.08B
Net Income/Loss:
$-20.76M
P/E Ratio:
-70.17
EPS:
-0.46
Net Cash Flow:
$151.63M
1W Performance:
-13.32%
1M Performance:
-19.75%
6M Performance:
-25.21%
1Y Performance:
+16.28%
1-Day Range:
$32.23
$33.47
1-Week Range:
$32.23
$38.25
52-Week Range:
$25.12
$55.74
Omnicell Inc Stock (OMCL) Company Profile
Name
Omnicell Inc
Sector
Industry
Phone
(877) 415-9990
Address
4220 NORTH FREEWAY, FORT WORTH
Compare OMCL with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
OMCL
Omnicell Inc
|
32.28 | 1.48B | 1.08B | -20.76M | 151.63M | -0.46 |
|
VEEV
Veeva Systems Inc
|
227.80 | 36.98B | 2.75B | 714.14M | 1.09B | 4.33 |
|
SOLV
Solventum Corp
|
72.30 | 12.51B | 8.26B | 66.00M | 1.17B | 0.3682 |
|
DOCS
Doximity Inc
|
60.80 | 11.41B | 516.85M | 174.11M | 217.38M | 0.87 |
|
HQY
Healthequity Inc
|
93.97 | 8.14B | 1.15B | 96.70M | -161.99M | 1.09 |
|
TEM
Tempus Ai Inc
|
42.16 | 7.26B | 640.44M | -743.28M | -206.93M | -11.29 |
Omnicell Inc Stock (OMCL) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-31-24 | Downgrade | BofA Securities | Buy → Neutral |
| Aug-02-24 | Upgrade | Barclays | Underweight → Equal Weight |
| Jan-03-24 | Initiated | Barclays | Underweight |
| Nov-03-23 | Downgrade | BTIG Research | Buy → Neutral |
| Nov-03-23 | Upgrade | Piper Sandler | Neutral → Overweight |
| Nov-03-23 | Upgrade | Wells Fargo | Underweight → Equal Weight |
| Oct-11-23 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| Sep-26-23 | Reiterated | Wells Fargo | Underweight |
| Aug-02-23 | Downgrade | Piper Sandler | Overweight → Neutral |
| Jul-20-23 | Downgrade | Wells Fargo | Overweight → Underweight |
| Feb-27-23 | Upgrade | The Benchmark Company | Hold → Buy |
| Nov-03-22 | Downgrade | The Benchmark Company | Buy → Hold |
| Sep-16-22 | Initiated | KeyBanc Capital Markets | Overweight |
| Sep-09-22 | Initiated | BofA Securities | Buy |
| Jul-15-22 | Initiated | SVB Leerink | Mkt Perform |
| Dec-06-21 | Resumed | Wells Fargo | Overweight |
| Jun-09-21 | Initiated | JP Morgan | Neutral |
| May-24-21 | Initiated | BTIG Research | Buy |
| Feb-02-21 | Upgrade | Piper Sandler | Neutral → Overweight |
| Dec-08-20 | Initiated | Berenberg | Buy |
| Dec-03-20 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| Jul-07-20 | Initiated | Stephens | Overweight |
| Feb-07-20 | Reiterated | Dougherty & Company | Buy |
| Nov-21-19 | Reiterated | Dougherty & Company | Buy |
| Jul-26-19 | Upgrade | Craig Hallum | Hold → Buy |
| Mar-07-19 | Reiterated | Dougherty & Company | Buy |
| Jun-29-18 | Resumed | The Benchmark Company | Buy |
| Sep-05-17 | Reiterated | The Benchmark Company | Buy |
| Jul-28-17 | Reiterated | Dougherty & Company | Buy |
| Apr-21-17 | Downgrade | Piper Jaffray | Overweight → Neutral |
| Jan-19-17 | Initiated | Dougherty & Company | Buy |
| Dec-06-16 | Reiterated | The Benchmark Company | Buy |
| Jul-07-16 | Reiterated | FBR Capital | Outperform |
| Mar-21-16 | Reiterated | Topeka Capital Markets | Buy |
| Jan-07-16 | Initiated | The Benchmark Company | Buy |
| Nov-16-15 | Reiterated | Topeka Capital Markets | Buy |
| Oct-30-15 | Reiterated | FBR Capital | Outperform |
| Sep-28-15 | Upgrade | Sidoti | Neutral → Buy |
| Jul-31-15 | Reiterated | Topeka Capital Markets | Buy |
View All
Omnicell Inc Stock (OMCL) Latest News
Omnicell CFO Nchacha Etta to step down in September By Investing.com - Investing.com Australia
Omnicell's (NASDAQ:OMCL) Earnings Seem To Be Promising - Yahoo Finance
Fort Worth-Based Omnicell CFO Nchacha Etta to Step Down as Company Initiates National Search - Fort Worth Inc.
BofA cuts Omnicell stock target to $38, maintains neutral rating By Investing.com - Investing.com UK
Omnicell Announces Chief Financial Officer Transition - 01Net
Omnicell CFO to step down, co reiterates first quarter and full year outlook -March 12, 2025 at 10:28 am EDT - Marketscreener.com
Omnicell CFO to step down, co reiterates first quarter and full year outlook - TradingView
Omnicell CFO set to depart By Investing.com - Investing.com Canada
Omnicell CFO Nchacha Etta to step down - TipRanks
Omnicell CFO Nchacha Etta Announces Departure - TipRanks
Omnicell CFO Nchacha Etta to step down in September - Investing.com India
Omnicell, Inc. Announces Step Down of Nchacha Etta as Executive Vice President Effective September 15, 2025 - Marketscreener.com
Omnicell, Inc. to Host Earnings Call - ACCESS Newswire
Omnicell, Inc. (NASDAQ:OMCL) Shares Sold by Bank of New York Mellon Corp - Defense World
QRG Capital Management Inc. Sells 353 Shares of Omnicell, Inc. (NASDAQ:OMCL) - Defense World
Omnicell (NASDAQ:OMCL) Raised to “Buy” at StockNews.com - Defense World
Omnicell Gains 41.6% in a Year: What's Driving the Stock? - MSN
Omnicell CEO secures employment agreement through 2027 By Investing.com - Investing.com Canada
Omnicell CEO secures employment agreement through 2027 - Investing.com
Omnicell Secures CEO Randall Lipps Through 2027 - TipRanks
Medication Management System Market Is Booming Worldwide - openPR
What is Zacks Research’s Forecast for Omnicell Q3 Earnings? - Defense World
FY2027 EPS Forecast for Omnicell Decreased by Analyst - Defense World
Omnicell FY2027 EPS Estimate Reduced by Zacks Research - MarketBeat
Principal Financial Group Inc. Raises Holdings in Omnicell, Inc. (NASDAQ:OMCL) - MarketBeat
Wakefield Asset Management LLLP Takes Position in Omnicell, Inc. (NASDAQ:OMCL) - MarketBeat
Principal Financial Group Inc. Buys 9,267 Shares of Omnicell, Inc. (NASDAQ:OMCL) - Defense World
Zacks Research Forecasts Omnicell FY2027 Earnings - MarketBeat
South Dakota Investment Council Sells 11,000 Shares of Omnicell, Inc. (NASDAQ:OMCL) - MarketBeat
Decoding Omnicell Inc (OMCL): A Strategic SWOT Insight - GuruFocus.com
Is it Apt to Retain Omnicell Stock in Your Portfolio Now? - Nasdaq
3 Healthcare Stocks Skating on Thin Ice - The Globe and Mail
Q1 Earnings Estimate for Omnicell Issued By Zacks Research - Defense World
Investor Network: Omnicell, Inc. to Host Earnings Call - ACCESS Newswire
OMNICELL, INC. SEC 10-K Report - TradingView
Zacks Research Predicts Omnicell's Q1 Earnings (NASDAQ:OMCL) - MarketBeat
Zacks Research Comments on Omnicell FY2027 Earnings - Defense World
Privia Health (PRVA) Q4 Earnings Report Preview: What To Look For - The Globe and Mail
Astrana Health (ASTH) To Report Earnings Tomorrow: Here Is What To Expect - The Globe and Mail
Omnicell (OMCL) Upgraded to Buy: What Does It Mean for the Stock? - MSN
6,681 Shares in Omnicell, Inc. (NASDAQ:OMCL) Bought by Vontobel Holding Ltd. - MarketBeat
Pharmacy Automation Market Is Booming Worldwide 2025-2032 | - openPR
Vontobel Holding Ltd. Takes $297,000 Position in Omnicell, Inc. (NASDAQ:OMCL) - Defense World
Omnicell (OMCL) Introduces Central Med Automation Service - MSN
Martin & Co. Inc. TN Sells 10,302 Shares of Omnicell, Inc. (NASDAQ:OMCL) - MarketBeat
Empowered Funds LLC Makes New $388,000 Investment in Omnicell, Inc. (NASDAQ:OMCL) - MarketBeat
Evolent Health (EVH) Q4 Earnings Report Preview: What To Look For - The Globe and Mail
Medication Management System Market Future Business - openPR
Rice Hall James & Associates LLC Raises Stock Holdings in Omnicell, Inc. (NASDAQ:OMCL) - MarketBeat
Omnicell's SWOT analysis: healthcare tech firm's stock faces growth hurdles - MSN
Omnicell's SWOT analysis: healthcare tech firm's stock faces growth hurdles By Investing.com - Investing.com Nigeria
Omnicell Inc Stock (OMCL) Financials Data
Revenue
Net Income
Cash Flow
EPS
5.27%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):